Company: MVNC
Filing Date: 2025-01-21
Form Type: DEF 14C
Source: 0001683168-25-000446
Chunk: 16

Company: Marvion Inc.
Filing Date: 2025-01-21
Form: DEF 14C
Chunk 16
---
 executive officers other than the principal executive officer and the principal financial officer who were serving
as executive officers on December 31, 2023, whose total compensation was in excess of $100,000, and (iv) up to two additional individuals
who would have been within the two-other-most-highly compensated but were not serving as executive officers on December 31, 2023.

<div align='center'>SUMMARY COMPENSATION TABLE</div>

| Name and Principal Position          |     | Year |     | Salary |     | Bonus |     | Stock  
 Awards |     | Option 
 Awards |     | Non-Equity   
 Incentive    
 Plan         
 Compensation |     | Change in     
 Pension       
 Value and     
 Non-qualified 
 Deferred      
 Compensation  
 Earnings      |     | All Other    
 Compensation |     | Total |   |
|:-------------------------------------|:----|-----:|:----|:-------|:----|:------|:----|:-------|:----|:-------|:----|:-------------|:----|:--------------|:----|:-------------|:----|:------|:--|
| Chan Sze Yu                          |     | 2023 |     | –      |     | –     |     | –      |     | –      |     | –            |     | –             |     | –            |     | $     | – |
| CEO, CFO, Secretary and Director (1) |     |      |     |        |     |       |     |        |     |        |     |              |     |               |     |              |     |       |   |
| Chan Man Chung                       |     | 2023 |     | –      |     | –     |     | –      |     | –      |     | –            |     | –             |     | –            |     | $     | – |
| CEO, CFO, Secretary and Director (2) |     | 2022 |     | –      |     | –     |     | –      |     | –      |     | –            |     | –             |     | –            |     | $     | – |

(1) Chan Sze Yu joined us as our Chief Executive Officer, Chief Financial
Officer, Secretary and Director on August 12, 2024.

(2) Dr. Chan served as our Chief Executive Officer, Secretary and Director
from August 26, 202